Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors

2000390 citationsJournal Articlebronze Open Access

Authors

Frank M. Sacks · University of Sydney

Andrew Tonkin · The University of Texas Health Science Center at Houston

James Shepherd · University of Sydney

Eugene Braunwald · National Heart Foundation of Australia

Stuart M. Cobbe · National Heart Foundation of Australia

C. Hawkins · The University of Texas Health Science Center at Houston

Anthony Keech

Abstract

Pravastatin treatment is effective in reducing coronary heart disease events in patients with high or low risk factor status and across a wide range of pretreatment lipid concentrations.

Topics & Keywords

Lipoproteins and Cardiovascular Health Lipid metabolism and disorders Diabetes, Cardiovascular Risks, and Lipoproteins

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 102, Issue 16, pp. 1893-1900

DOI: 10.1161/01.cir.102.16.1893

Field-Weighted Citation Impact: 41.06